OVERVIEW

Utilizing the Molecular/Physiologic Phenotype to Direct Asthma Therapy: A Comprehensive Infographic View is organized by Med Learning Group and will be held from Dec 14, 2018 - Dec 14, 2019.

Target Audience:
This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists, ENTs and primary care physicians who are involved in the healthcare of patients with moderate-to-severe asthma.

Accreditation:
Physicians
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med Learning Group designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with asthma.

CNE Credits:
1.0 ANCC Contact Hour(s)

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

Description:
This enduring activity will cover the diagnosis, treatment and management of patients with asthma and the correlation between asthma and nasal polyps.

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Assess the causes of underlying inflammation in asthma and resulting targets of therapy
• Evaluate the level of asthma control, disease severity, and exacerbation risk to better drive appropriate treatment
• Review currently available and novel targeted therapies and their effect on treatment strategies for patients with moderate-to-severe asthma

Additional details will be posted as soon as they are available.